AR059992A1 - Composiciones y metodos para mejorar la vasodilatacion - Google Patents

Composiciones y metodos para mejorar la vasodilatacion

Info

Publication number
AR059992A1
AR059992A1 ARP070101136A ARP070101136A AR059992A1 AR 059992 A1 AR059992 A1 AR 059992A1 AR P070101136 A ARP070101136 A AR P070101136A AR P070101136 A ARP070101136 A AR P070101136A AR 059992 A1 AR059992 A1 AR 059992A1
Authority
AR
Argentina
Prior art keywords
vasodilation
vasodilatation
compositions
improve
methods
Prior art date
Application number
ARP070101136A
Other languages
English (en)
Inventor
Bonney Oommen
Jessica Anne Marshall
Stanley Adam Wrobel
Brent Petersen
Loren Spencer Ward
Eric Bastian
Original Assignee
Glanbia Nutritionals Ireland L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glanbia Nutritionals Ireland L filed Critical Glanbia Nutritionals Ireland L
Publication of AR059992A1 publication Critical patent/AR059992A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Reivindicacion 1: Una composicion dietaria caracterizada porque comprende: un primer componente que incluye lactoferrina; un segundo componente que incluye péptidos inhibidores de la enzima convertidora de angiotensina; donde los componentes están incluidos en cantidades eficaces para estimular la vasodilatacion en un individuo. Reivindicacion 17: Un método para mejorar la vasodilatacion en un individuo, caracterizado porque comprende: ingerir una composicion antes del ejercicio, donde la composicion incluye lactoferrina y péptidos inhibidores de la enzima convertidora de angiotensina en una cantidad eficaz para aumentar el efecto de vasodilatacion resultante del ejercicio.
ARP070101136A 2006-03-20 2007-03-20 Composiciones y metodos para mejorar la vasodilatacion AR059992A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74357906P 2006-03-20 2006-03-20

Publications (1)

Publication Number Publication Date
AR059992A1 true AR059992A1 (es) 2008-05-14

Family

ID=38457812

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101136A AR059992A1 (es) 2006-03-20 2007-03-20 Composiciones y metodos para mejorar la vasodilatacion

Country Status (5)

Country Link
US (1) US20080038320A1 (es)
AR (1) AR059992A1 (es)
PE (1) PE20080037A1 (es)
UY (1) UY30227A1 (es)
WO (1) WO2007109681A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080268038A1 (en) * 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
US7790688B2 (en) * 2008-01-11 2010-09-07 Healthspan Solutions, Llc Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
US8716249B2 (en) * 2008-01-31 2014-05-06 Energy Light Llc Compositions and methods for improving cardiovascular health
PL2274002T3 (pl) * 2008-03-26 2015-06-30 Glanbia Nutritionals Ireland Ltd Kompozycje peptydów bogatych w leucynę i sposoby wydzielania
US20090276229A1 (en) * 2008-04-30 2009-11-05 Martin Grigorov Methods of monitoring the effect of nutritional products
US20120178672A1 (en) * 2009-03-18 2012-07-12 Wolfe Robert R Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
JP7123977B2 (ja) * 2017-05-31 2022-08-23 協和発酵バイオ株式会社 筋量を増大させるためのシトルリンおよびグルタチオンの使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
EP1079890A4 (en) * 1998-05-08 2008-12-03 Genetronics Inc VASODILATION OF AN ELECTRICALLY INDUCED VESSEL
US7737147B2 (en) * 2000-07-27 2010-06-15 Thomas Nadackal Thomas Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
US7090858B2 (en) * 2001-08-09 2006-08-15 Swaminathan Jayaraman Coated filter bag material for oral administration of medicament in liquid and methods of making same
EP1581243A4 (en) * 2002-12-06 2008-01-02 Agennix Inc ORAL LACTOFERRINE FOR THE TREATMENT OF SEPSIES
US20070172474A1 (en) * 2004-04-02 2007-07-26 University Of Tennessee Research Foundiation Dairy components effective for fat loss

Also Published As

Publication number Publication date
US20080038320A1 (en) 2008-02-14
WO2007109681A2 (en) 2007-09-27
WO2007109681A3 (en) 2007-11-08
PE20080037A1 (es) 2008-04-04
UY30227A1 (es) 2007-10-31

Similar Documents

Publication Publication Date Title
AR059992A1 (es) Composiciones y metodos para mejorar la vasodilatacion
AR056816A1 (es) Composicion con ácido docosapentenoico
BRPI0814726A2 (pt) fortificação de produtos nutricionais com extratos de oliveiras contendo hidroxitirosol e produtos nutricionais fortificados com hidroxitirosol
NO20083202L (no) ANG2- og VEFG-inhibitorkombinasjoner
BR122020000059B8 (pt) composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
DOP2006000216A (es) Composicion que enmascara el sabor metalico
GT200600280A (es) Composiciones y metodos para el tratamiento de sintomas relacionados con el ciclo
MY146969A (en) Dpp iv inhibitor formulations
WO2010065491A3 (en) Methods of treating inflammatory disorders
WO2006078774A3 (en) Regulation of autophagy and cell survival
MY153573A (en) Compositions and methods of use for antibodies of dickkopf-1
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
WO2005110404A3 (en) Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent
SV2009002862A (es) Composiciones de suplementos de hierro de tolerancia mejorada
EA201001845A1 (ru) Высокоэффективный антиокислитель на основе трегалулозы
BRPI0606766A2 (pt) produtos nutricionais para tratamento dos sintomas da artrite reumatóide
DK2124613T3 (da) Sammensætninger og fremgangsmåder til kontrol af kæledyrs vægt
MX2009005114A (es) Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
PE20141301A1 (es) Composiciones nutricionales a base de leche fortificada
TW200726460A (en) Anti-fatigue composition
AR074302A1 (es) Trans-clomifeno para el sindrome metabolico y la diabetes mellitus tipo 2.. metodo
BR112012016054A2 (pt) Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico
TW200744676A (en) Pharmaceutical compositions for the eradication of helicobacter pylori
WO2006089211A3 (en) Combat/training antioxidant micronutrient formulation and method of administration

Legal Events

Date Code Title Description
FB Suspension of granting procedure